|Positive WB detected in||mouse skeletal muscle tissue, rat skeletal muscle tissue|
|Western Blot (WB)||WB : 1:1000-1:4000|
|Sample-dependent, check data in validation data gallery|
11427-1-AP targets ANKRD1 in WB, IF, ELISA applications and shows reactivity with human, mouse, rat samples.
|Tested Reactivity||human, mouse, rat|
|Cited Reactivity||human, mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||ANKRD1 fusion protein Ag1970|
|Full Name||ankyrin repeat domain 1 (cardiac muscle)|
|Calculated molecular weight||319 aa, 36 kDa|
|Observed molecular weight||36 kDa|
|GenBank accession number||BC018667|
|Gene ID (NCBI)||27063|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
Ankyrin repeat domain-containing protein 1(ANKRD1) belongs to the conserved muscle ankyrin repeat protein(MARP) family, whose expression is induced in response to physiologic stress, injury and hypertrophy. Thus its expression mainly in activated vascular endothelial cells. ANKRD1 may regulate SMC proliferation through the CDKN1A pathway. It functions as a nuclear transcription repressor that regulate cardiac gene's expression. This is a rabbit polyclonal antibody produced by the full-length ANKRD1 of human origin
Nat Cell Biol
Metabolic control of YAP and TAZ by the mevalonate pathway.
YAP1/TAZ drives ependymoma-like tumour formation in mice.
ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer.
Glucocorticoid receptor signalling activates YAP in breast cancer.
Hum Mol Genet
Exploiting The CRISPR/CAS9 System to Study Alternative Splicing In Vivo: Application to Titin.
Cell Death Dis
The histone code reader Spin1 controls skeletal muscle development.
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
Luigi (Verified Customer) (11-29-2018)